Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 4 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Melanoma 1 Head and Neck Neoplasms 1

Interventions

pembrolizumab 51 Carboplatin 21 Paclitaxel 20 Cyclophosphamide 18 Nivolumab 13 Taxes 10 130-nm albumin-bound paclitaxel 10 olaparib 9 Specimen Handling 9 spartalizumab 8 fludarabine 8 Doxorubicin 8 durvalumab 7 Magnetic Resonance Spectroscopy 7 Gemcitabine 7 Cisplatin 7 Biopsy 7 veliparib 6 atezolizumab 6 Fulvestrant 6 Albumin-Bound Paclitaxel 6 liposomal doxorubicin 5 eribulin 5 budigalimab 5 Irinotecan 5 Ipilimumab 5 aldesleukin 4 Radiotherapy 4 Oxaliplatin 4 Leucovorin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Triple Negative Breast Neoplasms × Electroporation × Clear all

NCT02531425 2023-05-15

TNBC

OncoSec Medical Incorporated

Phase 1 Completed

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡